DKS Earnings: Highlights of DICK’S Sporting Goods’ Q4 2023 results

Watch Icon
DKS Earnings: Highlights of DICK’S Sporting Goods’ Q4 2023 results

DICK’S Sporting Goods, Inc. (NYSE: DKS) on Thursday announced financial results for the fourth quarter of 2023, reporting an increase in sales and profit.

Net sales of the sportswear company increased 8% year-over-year to $3.88 billion in the January quarter. Comparable store sales rose 2.8%, which is slower than the 5.3% growth achieved in the prior-year quarter.

Net income, on a reported basis, increased to $296 million or $3.57 per share in the fourth quarter from $236 million or $2.60 per share last year. Adjusted earnings were $3.85 per share, up 31%.

“With our industry-leading assortment and strong execution, we capped off the year with an incredibly strong fourth quarter and holiday season. Even excluding the extra week, this was the largest sales quarter in the history of the Company, and during the fourth quarter, we drove significant gross margin and EBT margin expansion. Our full year comps increased 2.4%, driven by growth in transactions, and we continued to gain market share,” said Lauren Hobart, CEO of DICK’s Sporting.

Prior Performance

The post DKS Earnings: Highlights of DICK’S Sporting Goods’ Q4 2023 results first appeared on AlphaStreet.


Regenx Launches Revenue Phase | Financial Post |

Read More | Article content EDMONTON, Alberta, Feb. 15, 2024 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3) announces the first shipment of its black powder concentrate to a refiner from its Greeneville, Tennessee facility. The initial shipment was approximately 1 kg of material that was […]

Kirby McInerney LLP Reminds B. Riley Financial, Inc. (RILY) Investors of Class Action Filing and Encourages Investors to Contact the FirM |

Read More | Article content NEW YORk, Feb. 02, 2024 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired B. Riley Financial, Inc. (“B. Riley” or the […]

Is Viking Therapeutics Stock a Buy? |

Read More | With Viking Therapeutics (NASDAQ: VKTX) stock exploding skyward by 528% over the last 12 months, it’s easy to wonder if the opportunity to buy its stock is too good to be true — and a bit too late. But in this case, there’s actually a well-grounded argument for why shares of this […]